AD is clinically characterized by a progressive, global cognitive impairment that affects a person’s ability to perform everyday activities and is associated with brain changes that involve the extracellular accumulation of beta-amyloid plaques outside neurons and intraneuronal deposition of tau tangles inside neurons [2]. Here, MAPT is linked to Cognitive impairment.